AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
116 hedge funds and large institutions have $596M invested in Aerie Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 40 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 115 → 116 (+1)
10% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 40
Holders
116
Holding in Top 10
6
Calls
$3.53M
Puts
$2.4M
Top Buyers
| 1 | +$12.1M | |
| 2 | +$7.93M | |
| 3 | +$3.81M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.71M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.04M |
Top Sellers
| 1 | -$17.5M | |
| 2 | -$4.09M | |
| 3 | -$3.55M | |
| 4 |
Barclays
London,
United Kingdom
|
-$3.49M |
| 5 |
WC
Weatherbie Capital
Boston,
Massachusetts
|
-$3.13M |